AbCellera Biologics Inc. (ABCL) /
The profitability of AbCellera Biologics Inc. over the past 7 years
Chart AbCellera Biologics Inc.: operating income, net income, fiscal 2019–2025 Open the chart →AbCellera Biologics Inc. reported a net loss of $146.41M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $217.1M. It reported a profit in 3 of the 7 years shown, and a loss in fiscal 2019, 2023, 2024 and 2025. Its highest net income in these years was $158.52M, in fiscal 2022.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$217.1M | -$146.41M |
| 2024ended Dec 31, 2024 | -$314.77M | -$162.86M |
| 2023ended Dec 31, 2023 | -$237.21M | -$146.4M |
| 2022ended Dec 31, 2022 | $216.51M | $158.52M |
| 2021ended Dec 31, 2021 | $204.41M | $153.46M |
| 2020ended Dec 31, 2020 | $156.03M | $118.92M |
| 2019ended Dec 31, 2019 | -$4.12M | -$2.21M |
Fiscal years as AbCellera Biologics Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on AbCellera Biologics Inc.
- The revenue of AbCellera Biologics Inc.
- The cash flow of AbCellera Biologics Inc.
- The debt of AbCellera Biologics Inc.
- All of AbCellera Biologics Inc.'s financials, charted
Companies of a similar size
- GEOThe GEO Group, Inc.
- RUSHARUSH ENTERPRISES, INC.
- EQPTEquipmentShare.com Inc
- SLMSLM Corp
- ACMRACM Research, Inc.
Not investment advice. This page shows what AbCellera Biologics Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.